Follow the Camurus AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Camurus AB has logged 7 reports. Market capitalisation: €30.2bn. The latest transaction was disclosed on 30 September 2025 (Sale). Among the most active insiders: Annette Mattsson. The full history is openly available.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€441,407
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Camurus AB Strong Buy (bullish), based on 8 analysts. Average price target: SEK 770.13.
30Σ signal
Buys ·€441,407 Sells
Fundamental score
Ranked 6,880 of 25,899 companies
63.3
score / 100
Value
36
Quality
91
FCF yld2.3%
Earn yld2.3%
EV/EBITDA33.7x
ROE17%
Gross mgn93%
Net mgn32%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.